An immunohistochemical study of altered immunomodulatory molecule expression in head and neck squamous cell carcinoma
1997

Study of HLA Class I Molecule Expression in Head and Neck Cancer

Sample size: 34 publication Evidence: moderate

Author Information

Author(s): AR Vora, S Rodgers, AJ Parker, R Start, RC Rees, AK Murray

Primary Institution: University of Sheffield

Hypothesis

The expression of HLA class I molecules is altered in head and neck squamous cell carcinoma, affecting immune response.

Conclusion

Altered expression of HLA class I molecules in head and neck squamous cell carcinoma may impact prognosis and immunotherapy strategies.

Supporting Evidence

  • 50% of specimens showed aberrant allelic expression of HLA class I antigens.
  • Decreased expression of ICAM-1 was observed in 35% of tumor specimens.
  • 38% of cases showed de novo expression of HLA-DR by carcinoma cells.
  • Altered expression of immunomodulatory molecules may affect prognosis.
  • High positive staining values for TAP proteins were found.

Takeaway

This study looked at how certain proteins that help the immune system recognize cancer cells are changed in head and neck cancer, which could affect treatment.

Methodology

Immunohistochemistry was used to examine HLA class I expression in frozen head and neck squamous cell carcinoma specimens.

Limitations

The study had a limited sample size and lacked follow-up data to draw definitive conclusions.

Participant Demographics

30 male and 4 female patients, aged 49-83 years (mean age 64 years).

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication